X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/calico-life-sciences-announces-first-participant-dosed-in-phase-1b-clinical-study-evaluating-abbv-cls-7262-for-the-treatment-of-vanishing-white-matter-disease-301807584.html
https://www.biospace.com/article/terray-and-calico-strike-biotech-s-latest-r-and-d-deal-against-age-related-diseases/